Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Mar;23(3):101-109.
doi: 10.1016/j.bjae.2022.10.003. Epub 2023 Jan 4.

Systemic sclerosis. Part II: perioperative considerations

C I Efrimescu  1 , S Donnelly  1   2 , D J Buggy  1   2
Affiliations
Review

Systemic sclerosis. Part II: perioperative considerations

C I Efrimescu et al. BJA Educ. 2023 Mar.
No abstract available

Keywords: anaesthesia; hypertension; perioperative care; pulmonary; scleroderma; systemic.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest.

Figures

Fig 1
Fig 1
The DETECT algorithm for PAH screening in systemic sclerosis. Electronic option available for Android and iOS. Adapted from Coghlan and colleagues. ACA, anticardiolipin antibodies; FVC, forced vital capacity; NTproBNP, N-terminal pro B-type natriuretic peptide; PAH, pulmonary arterial hypertension; TR, tricuspid regurgitation.
See this image and copyright information in PMC

References

    1. Pokeerbux M.R., Giovannelli J., Dauchet L., et al. Survival and prognosis factors in systemic sclerosis: data of a French multicenter cohort, systematic review, and meta-analysis of the literature. Arthritis Res Ther. 2019;21:86. - PMC - PubMed
    1. Efrimescu C., Donnelly S., Buggy D.J. Systemic sclerosis. Part I: epidemiology, diagnosis and therapy. BJA Educ. 2023;23(2) - PMC - PubMed
    1. Hachulla E., Agard C., Allanore Y., et al. French recommendations for the management of systemic sclerosis. Orphanet J Rare Dis. 2021;16:322. - PMC - PubMed
    1. Jaeger V.K., Wirz E.G., Allanore Y., et al. Incidences and risk factors of organ manifestations in the early course of systemic sclerosis: a longitudinal EUSTAR study. PLoS One. 2016;11 - PMC - PubMed
    1. Yazdany J., Manno R., Hellmann D.B., et al. In: Current medical diagnosis & treatment 2021. Papadakis M.A., McPhee S.J., Rabow M.W., editors. McGraw-Hill Education; New York, NY: 2021. Scleroderma (systemic sclerosis)